|
시장보고서
상품코드
1762257
신경자극 기기 시장 규모, 점유율, 동향, 산업 분석 보고서 : 용도별, 기기별, 지역별 - 시장 예측(2025-2034년)Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application, Devices, and Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 신경자극 기기 시장 규모는 2034년까지 236억 3,000만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
신경자극 기기 시장은 신경 활동을 조절하기 위해 신경계에 전기적 자극을 공급하는 의료기기로 구성되며, 주로 만성 통증, 간질, 파킨슨병, 본태성 진전, 기타 신경 질환의 관리에 사용됩니다.
신경 질환의 유병률 증가, 최소침습적 치료 옵션에 대한 수요 증가, AI 통합 및 무선 자극과 같은 기술 발전으로 인해 신경자극 기기 시장은 크게 성장하고 있습니다. 신경자극 기기의 시장 기회는 신흥 시장에서 이러한 장치의 채택 확대와 함께 인지 장애 및 비만 관리와 같은 기존 적응증 외의 다른 용도로의 확장에 있습니다.
주요 동향으로는 충전식 및 소형화 장치 개발, 업계 플레이어 간의 전략적 제휴, 신경자극 기기 시장 확대를 촉진하는 규제 당국의 승인 등이 있습니다. 헬스케어 인프라가 구축되고 인지도가 높아짐에 따라 시장은 기술 혁신과 진화하는 환자들의 요구에 힘입어 꾸준한 성장세를 보이고 있습니다.
신경자극 기기 시장 보고서 하이라이트
용도별로는 만성 통증 질환의 유병률 증가와 척수 자극기 채택 증가로 인해 통증 관리 분야가 가장 큰 시장 점유율을 차지하고 있습니다.
기기별로는 파킨슨병, 본태성 진전 등 운동장애에 대한 사용 확대에 힘입어 뇌심부자극기가 가장 빠르게 성장하고 있습니다.
북미는 높은 의료비 지출, 강력한 규제 당국의 승인, 신경자극 기기의 보급으로 시장을 선도하고 있습니다.
아시아태평양은 의료 인프라 개선, 인지도 향상, 신경질환 유병률 증가 등을 배경으로 큰 성장세를 보이고 있습니다.
신경자극 기기 시장에는 의료 기술 발전에 적극적으로 기여하고 있는 여러 주요 기업들이 있습니다. 주요 기업으로는 Abbott Laboratories, Aleva Neurotherapeutics, Boston Scientific Corporation, Cognito Therapeutics, ElectroCore, Inc, LivaNova PLC, Medtronic plc, Nalu Medical, Inc, Neuronetics, Inc, NeuroPace, Inc, Nevro Corp. Medtronic plc, Nalu Medical, Inc, Neuronetics, Inc, NeuroPace, Inc, Nevro Corp, Synapse Biomedical Inc 등이 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 조사 방법
제4장 세계의 신경자극 기기 시장 인사이트
- 시장 현황
- 신경자극 기기 시장 역학
- 성장 촉진요인과 기회
- 신경질환 유병률 상승
- 신경자극 기술의 진보
- 성장 억제요인과 과제
- 기기와 시술의 고비용
- 성장 촉진요인과 기회
- PESTEL 분석
- 신경자극 기기 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 신경자극 기기 시장 : 용도별
- 주요 조사 결과
- 소개
- 통증 관리
- 간질
- 본태성진전
- 요실금과 변실금
- 우울증
제6장 세계의 신경자극 기기 시장 : 기기별
- 주요 조사 결과
- 소개
- 척수자극 기기
- 뇌심부자극 기기
- 천골신경자극 기기
- 미주신경자극 기기
- 위전기자극 기기
제7장 세계의 신경자극 기기 시장 : 지역
- 주요 조사 결과
- 소개
- 신경자극 기기 시장 분석 : 지역, 2020-2034년
- 북미
- 북미 : 용도별, 2020-2034년
- 북미 : 기기별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 용도별, 2020-2034년
- 유럽 : 기기별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 기기별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 기기별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 기기별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제9장 기업 개요
- Abbott Laboratories
- Advanced Bionics(a Sonova Group company)
- Aleva Neurotherapeutics
- Boston Scientific Corporation
- Cochlear Limited
- Cognito Therapeutics
- ElectroCore, Inc.
- Inspire Medical Systems, Inc.
- LivaNova PLC
- Medtronic plc
The global neurostimulation devices market size is expected to reach USD 23.63 billion by 2034, according to a new study by Polaris Market Research. The report "Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application (Pain Management, Epilepsy, Essential Tremor, Urinary & Faecal Incontinence, and Depression), Devices, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The neurostimulation devices market consists of medical devices that deliver electrical impulses to the nervous system to modulate neural activity, primarily used for managing chronic pain, epilepsy, Parkinson's disease, essential tremor, and other neurological conditions.
The market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing demand for minimally invasive treatment options, and advancements in technology, including AI integration and wireless stimulation. Neurostimulation devices market opportunities lie in expanding applications beyond traditional indications, such as in cognitive disorders and obesity management, along with the growing adoption of these devices in emerging markets.
Key trends include the development of rechargeable and miniaturized devices, strategic collaborations among industry players, and regulatory approvals facilitating neurostimulation devices market expansion. As healthcare infrastructure improves and awareness increases, the market continues to witness steady growth, driven by innovation and evolving patient needs.
Neurostimulation Devices Market Report Highlights
By application, the pain management segment holds the largest market share due to the rising prevalence of chronic pain conditions and the increasing adoption of spinal cord stimulators.
By devices, the deep brain stimulators segment is experiencing the fastest growth, supported by their expanding use in movement disorders such as Parkinson's disease and essential tremor.
North America leads the market due to high healthcare spending, strong regulatory approvals, and widespread adoption of neurostimulation devices.
Asia Pacific is experiencing significant growth, driven by improving healthcare infrastructure, rising awareness, and increasing prevalence of neurological disorders.
The neurostimulation devices market features several key players actively contributing to advancements in medical technology. Prominent companies include Abbott Laboratories; Aleva Neurotherapeutics; Boston Scientific Corporation; Cognito Therapeutics; ElectroCore, Inc.; LivaNova PLC; Medtronic plc; Nalu Medical, Inc.; Neuronetics, Inc.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.
Polaris Market Research has segmented the neurostimulation devices market report on the basis of application, devices, and region:
By Application Outlook (Revenue - USD Billion, 2020-2034)
Pain Management
Epilepsy
Essential Tremor
Urinary & Faecal Incontinence
Depression
By Devices Outlook (Revenue - USD Billion, 2020-2034)
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Neurostimulation Devices Market Insights
- 4.1. Neurostimulation Devices Market - Market Snapshot
- 4.2. Neurostimulation Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Neurological Disorders
- 4.2.1.2. Advancements in Neurostimulation Technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Devices and Procedures
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurostimulation Devices Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Neurostimulation Devices Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 5.3. Pain Management
- 5.3.1. Global Neurostimulation Devices Market, by Pain Management, by Region, 2020-2034 (USD Billion)
- 5.4. Epilepsy
- 5.4.1. Global Neurostimulation Devices Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
- 5.5. Essential Tremor
- 5.5.1. Global Neurostimulation Devices Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
- 5.6. Urinary & Faecal Incontinence
- 5.6.1. Global Neurostimulation Devices Market, by Urinary & Faecal Incontinence, by Region, 2020-2034 (USD Billion)
- 5.7. Depression
- 5.7.1. Global Neurostimulation Devices Market, by Depression, by Region, 2020-2034 (USD Billion)
6. Global Neurostimulation Devices Market, by Devices
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 6.3. Spinal Cord Stimulator
- 6.3.1. Global Neurostimulation Devices Market, by Spinal Cord Stimulator, by Region, 2020-2034 (USD Billion)
- 6.4. Deep Brain Stimulator
- 6.4.1. Global Neurostimulation Devices Market, by Deep Brain Stimulator, by Region, 2020-2034 (USD Billion)
- 6.5. Sacral Nerve Stimulator
- 6.5.1. Global Neurostimulation Devices Market, by Sacral Nerve Stimulator, by Region, 2020-2034 (USD Billion)
- 6.6. Vagus Nerve Stimulator
- 6.6.1. Global Neurostimulation Devices Market, by Vagus Nerve Stimulator, by Region, 2020-2034 (USD Billion)
- 6.7. Gastric Electric Stimulator
- 6.7.1. Global Neurostimulation Devices Market, by Gastric Electric Stimulator, by Region, 2020-2034 (USD Billion)
7. Global Neurostimulation Devices Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Neurostimulation Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Neurostimulation Devices Market - North America
- 7.3.1. North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.3.2. North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.3.3. Neurostimulation Devices Market - U.S.
- 7.3.3.1. U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.3.4. Neurostimulation Devices Market - Canada
- 7.3.4.1. Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4. Neurostimulation Devices Market - Europe
- 7.4.1. Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.2. Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.3. Neurostimulation Devices Market - UK
- 7.4.3.1. UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.4. Neurostimulation Devices Market - France
- 7.4.4.1. France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.4.2. France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.5. Neurostimulation Devices Market - Germany
- 7.4.5.1. Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.6. Neurostimulation Devices Market - Italy
- 7.4.6.1. Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.7. Neurostimulation Devices Market - Spain
- 7.4.7.1. Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.8. Neurostimulation Devices Market - Netherlands
- 7.4.8.1. Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.9. Neurostimulation Devices Market - Russia
- 7.4.9.1. Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.4.10. Neurostimulation Devices Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5. Neurostimulation Devices Market - Asia Pacific
- 7.5.1. Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.3. Neurostimulation Devices Market - China
- 7.5.3.1. China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.3.2. China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.4. Neurostimulation Devices Market - India
- 7.5.4.1. India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.4.2. India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.5. Neurostimulation Devices Market - Malaysia
- 7.5.5.1. Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.6. Neurostimulation Devices Market - Japan
- 7.5.6.1. Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.7. Neurostimulation Devices Market - Indonesia
- 7.5.7.1. Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.8. Neurostimulation Devices Market - South Korea
- 7.5.8.1. South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.9. Neurostimulation Devices Market - Australia
- 7.5.9.1. Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.5.10. Neurostimulation Devices Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6. Neurostimulation Devices Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.3. Neurostimulation Devices Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.4. Neurostimulation Devices Market - UAE
- 7.6.4.1. UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.5. Neurostimulation Devices Market - Israel
- 7.6.5.1. Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.6. Neurostimulation Devices Market - South Africa
- 7.6.6.1. South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.6.7. Neurostimulation Devices Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7. Neurostimulation Devices Market - Latin America
- 7.7.1. Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.3. Neurostimulation Devices Market - Mexico
- 7.7.3.1. Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.4. Neurostimulation Devices Market - Brazil
- 7.7.4.1. Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.5. Neurostimulation Devices Market - Argentina
- 7.7.5.1. Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
- 7.7.6. Neurostimulation Devices Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Advanced Bionics (a Sonova Group company)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Aleva Neurotherapeutics
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Cochlear Limited
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Cognito Therapeutics
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. ElectroCore, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Inspire Medical Systems, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. LivaNova PLC
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Medtronic plc
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
